Associations of levetiracetam use with the safety and tolerability profile of chemoradiotherapy for patients with newly diagnosed glioblastoma

BACKGROUND: Levetiracetam (LEV) is one of the most frequently used antiepileptic drugs (AED) for brain tumor patients with seizures. We hypothesized that toxicity of LEV and temozolomide-based chemoradiotherapy may overlap. METHODS: Using a pooled cohort of patients with newly diagnosed glioblastoma...

Descripción completa

Detalles Bibliográficos
Autores principales: Seystahl, Katharina, Oppong, Felix Boakye, Le Rhun, Emilie, Hertler, Caroline, Stupp, Roger, Nabors, Burt, Chinot, Olivier, Preusser, Matthias, Gorlia, Thierry, Weller, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Clinical Investigations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9356690/
https://www.ncbi.nlm.nih.gov/pubmed/35950086
http://dx.doi.org/10.1093/noajnl/vdac112

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9356690/
https://www.ncbi.nlm.nih.gov/pubmed/35950086
http://dx.doi.org/10.1093/noajnl/vdac112

Ejemplares similares